黎明抗病毒试验:一般实践中COVID-19试验的过程评估
Dajana Tare1, Samuel Coenen2, An De Sutter3
1Academic Centre for General Practice, KU Leuven, Belgium.
BJGP open
|November 20, 2023
概括
由于招募人数较低,DAWN抗病毒药物对COVID-19的试验提前停止. 这些因素包括流行病的干扰,监管延迟和晚期启动,突出显示了对强大的研究基础设施的需求.
科学领域:
- 临床试验 临床试验
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- DAWN抗病毒药物试验是一项多中心,随机,安慰剂控制的研究,评估在一般实践中用于COVID-19的抗病毒药物.
- 该试验因参与者招募不足而过早结束.
研究的目的:
- 调查DAWN抗病毒试验提前终止背后的促成因素.
主要方法:
- 该研究是在比利时的一般实践中进行的.
- 参与者被随机分配到卡莫斯塔特或安慰剂,后来增加了一个开放标签的molnupiravir手臂.
- 数据分析包括试验数据和与利益相关者的半结构面试,以评估背景,实施和影响.
主要成果:
- 该试验在三个手臂 (camostat,molnupiravir,安慰剂) 中仅招募了44名参与者.
- 关键的挑战包括与疫情相关的临床服务中断,员工压倒,药物延迟和员工短缺.
- 漫长的监管流程和试验的延迟开始,与疫苗接种推广相吻合,也阻碍了招聘.
结论:
- 黎明抗病毒试验的过早终止受到了与流行病有关的障碍的影响.
- 克服诸如小型/缺乏经验的团队,监管延迟和有限的研究能力等障碍,需要建立基础设施和标准化流程.
相关概念视频
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Pharmacovigilance
857
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
857


